O2h Ventures — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Spireaspirea.co.ukinJun 2022 · $3M
Spirea develops a multivalent ADC linker technology called ELIVATE that expands the range of usable payloads for antibody-drug conjugates, aiming to enable next-generation ADCs for oncology, inflammation, and autoimmune diseases.
BiotechDeep TechHealthtech
Myriam Ouberai(Founder)inBo Rode Hansen(Executive Director)in
Co-investorsCambridge Angels groupStart CodonACF InvestorsR42 Group
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.